Where Will FMC Stock Be in 1 Year?
It’s an understatement to say that FMC (NYSE: FMC) investors have had a rough year. During this time frame, shares in the agricultural chemicals company have fallen by around two-thirds. Blame this on poor fiscal results and challenging industry conditions. Yet while this turn of events has been frustrating for existing investors, for those who have yet to enter a position, making FMC a bottom-fisher’s buy may not be such a bad idea. Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue » Consider that this stock, despite its troubles, has not one but two catalysts that could potentially play out over the next year. Image source: Getty Images. Various factors weigh on FMC shares Industry- and company-specific factors have both contributed to FMC’s worsening fiscal performance and stock price performance. The agricultural chemicals business, which spans insecticides, herbicides, and fungicides to crop nutrition and seed treatment products, is in a slump. Weak demand and oversupply have dampened sales and squeezed margins. Furthermore, FMC is facing patent expirations for many of its products. As a result, the company has experienced a meaningful drop in revenue and earnings since 2024. All figures below are adjusted for FMC’s sale of its India division last year. 2025 2024 % Change Revenue $3.9 billion $4.2 billion (8%) Adjusted EBITDA $843 million $906 million (7%) Adjusted Earnings per Share (EPS) $2.96 $3.48 (15%) Source: FMC With earnings and cash flow dwindling, FMC’s management has had to make some tough decisions for the long-term sake of the company. These have included a dividend cut, and, more recently, plans to consider “strategic alternatives,” including a possible sale of the company. Both these developments led a negative reaction from investors. The dividend cut of 86% led to a big sell-off among dividend-focused investors, as the stock lost its luster as one of the high-yield dividend stocks. News of “strategic alternatives” cast doubt on hopes that FMC would make a return to prior price levels. The silver lining for new investors FMC may come with a lot of baggage, but if you’ve yet to enter a position, this is less of a big deal than you would think. Yes, management has conceded that the situation isn’t set to immediately improve from here. For instance, per management’s 2026 guidance, revenue could fall by another 5.2% this year, to $3.6 billion. Guidance also calls for adjusted EBITDA to fall to between $670 million and $730 million, and for adjusted EPS to fall between $1.63 to $1.89.